Literature DB >> 952282

Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes.

S H Zinner, H S Margolius, B Rosner, H R Keiser, E H Kass.   

Abstract

Biochemical alterations that have been correlated with elevated blood pressure have not received extensive epidemiologic study because of the technical difficulties involved. Because the excretion of urinary kallikrein is reduced significantly in adult hypertensives, we have studied urinary kallikrein in a cohort of children in whom familial aggregation of blood pressure has been demonstrated. Casual specimens of urine were obtained in household surveys, and urinary concentration of kallikrein was determined in 601 children aged 5-18 years. The children were from 163 families, whose members also had their blood pressures measured. Familial aggregation of urinary kallikrein concentration was found by analysis of variance (F=3.45, p less than 0.001) even in these casual specimens and was demonstrable for black and white children analyzed separately. Urinary kallikrein concentration was significantly lower in black children than in white children (p less than 0.001) and was positively correlated with urinary creatinine and urinary potassium and inversely related to urinary sodium concentrations. Urinary kallikrein concentration also was being altered by season (being lowest in the summer) and by time of day (being highest in the morning). Families with the lowest mean kallikrein concentrations tended to have higher blood pressures than did families with the highest mean kallikrein concentrations, although the effect is small and subject to many variables.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952282     DOI: 10.1093/oxfordjournals.aje.a112282

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  18 in total

1.  Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children.

Authors:  James A MacKenzie; Kristen A Roosa; Brooks B Gump; Amy K Dumas; Kestutis G Bendinskas
Journal:  Appl Physiol Nutr Metab       Date:  2010-08       Impact factor: 2.665

Review 2.  Tissue kallikreins structure, regulation, and participation in mammalian physiology and disease.

Authors:  H S Margolius
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 3.  Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium, and calcium regulation.

Authors:  A Aviv; M Aladjem
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

4.  Evidence for environmental familiality of kallikrein excretion in Utah kindreds.

Authors:  M M Dadone; J B Smith; D L Anderton; K O Ash; R R Williams
Journal:  West J Med       Date:  1986-05

5.  Atrial natriuretic factor: a new hormone?

Authors:  I H Mills
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-28

6.  Familial determinants of blood pressure in northeastern Brazil.

Authors:  H Krieger; N E Morton; D C Rao; E Azevêdo
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

7.  Urinary prostaglandins in human neonates: relationship to kidney function and blood pressure.

Authors:  B Scherer; G Friedmann; A Dumbs; K Holzmann; P C Weber
Journal:  Klin Wochenschr       Date:  1980-05-02

8.  Kinin-forming system in the genesis of hypertension.

Authors:  J N Sharma
Journal:  Agents Actions       Date:  1984-02

9.  Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.

Authors:  Michel Azizi; Pierre Boutouyrie; Alvine Bissery; Mohsen Agharazii; Francis Verbeke; Nora Stern; Alessandra Bura-Rivière; Stéphane Laurent; François Alhenc-Gelas; Xavier Jeunemaitre
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

10.  Urinary kallikrein activity of workers exposed to lead.

Authors:  P Boscolo; G Porcelli; G Cecchetti; E Salimei; A Iannaccone
Journal:  Br J Ind Med       Date:  1978-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.